72
Participants
Start Date
May 17, 2022
Primary Completion Date
January 15, 2026
Study Completion Date
March 12, 2028
Bemarituzumab
Intravenous (IV) infusion
CAPOX
CAPOX administered as a combination of oxaliplatin as an IV infusion and capecitabine orally as tablets.
SOX
SOX administered as a combination of oxaliplatin as an IV infusion and S-1 orally.
Nivolumab
IV infusion.
National Taiwan University Hospital, Taipei
National Cancer Center, Goyang-si Gyeonggi-do
Taipei Veterans General Hospital, Taipei
Northport Veterans Affairs Medical Center, Northport
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do
National University Hospital, Singapore
Fujita Health University Hospital, Toyoake-shi
Hirosaki University Hospital, Hirosaki-shi
Chiba University Hospital, Chiba
National Hospital Organization Shikoku Cancer Center, Matsuyama
Fukui Prefectural Hospital, Fukui-shi
Kyushu University Hospital, Fukuoka
Fukushima Medical University Hospital, Fukushima
Gifu University Hospital, Gifu
Ogaki Municipal Hospital, Ogaki-shi
Gunma University Hospital, Maebashi
Gunma Prefectural Cancer Center, Ota-shi
Hiroshima City Hiroshima Citizens Hospital, Hiroshima
Hiroshima University Hospital, Hiroshima
Ibaraki Prefectural Central Hospital, Kasama-shi
Ishikawa Prefectural Central Hospital, Kanazawa
Kagawa University Hospital, Kita-gun
St Marianna University Hospital, Kawasaki-shi
Kanagawa Prefectural Hospital Organization Kanagawa Cancer Center, Yokohama
Kochi Health Sciences Center, Kochi
Kyoto University Hospital, Kyoto
Tohoku University Hospital, Sendai
Okayama University Hospital, Okayama
Osaka General Medical Center, Osaka
Osaka Medical and Pharmaceutical University Hospital, Takatsuki-shi
Shizuoka General Hospital, Shizuoka
Shizuoka Cancer Center, Sunto-gun
Dokkyo Medical University Hospital, Shimotsuga-gun
National Cancer Center Hospital, Chuo-ku
The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku
IMSUT Hospital, The Institute of Medical Science The University of Tokyo, Minato-ku
Toyama University Hospital, Toyama
Seoul National University Hospital, Seoul
Severance Hospital Yonsei University Health System, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Korea University Guro Hospital, Seoul
Lead Sponsor
Amgen
INDUSTRY